Rain Therapeutics Inc. — Form D
Rain Therapeutics Inc. of Newark, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-16. The offering totals $72.6M, of which $72.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-16
- Form: D
- Accession: 0001724979-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $72.6M
- Amount sold: $72.6M
- Remaining: $35
- Minimum investment: $1
- Investors: 18
- Date of first sale: 2020-09-02
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-375605
Issuer
- Name: Rain Therapeutics Inc.
- CIK: 0001724979
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 8000 Jarvis Avenue, Suite 204, Newark, CA, 94560
- Phone: (510) 255-4285
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Franklin Berger | Director | Newark, CA |
| Aaron Davis | Director | Miami, FL |
| Gorjan Hrustanovic | Director | San Diego, CA |
| Tran Nguyen | Director | Newark, CA |
| Peter Radovich | Director | Foster City, CA |
| Avanish Vellanki | Director | Newark, CA |
| Avanish Vellanki | Executive Officer | Newark, CA |
Other filings by this issuer (2)
More